14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OTLK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Outlook Therapeutics Inc. stock price down 0.92% on Monday
(Updated on Apr 15, 2024)

Buy or Hold candidate since Mar 19, 2024 Gain 16.41% PDF

The Outlook Therapeutics Inc. stock price fell by -0.92% on the last day (Monday, 15th Apr 2024) from $8.70 to $8.62. During the last trading day the stock fluctuated 4.15% from a day low at $8.44 to a day high of $8.79. The price has fallen in 7 of the last 10 days and is down by -15.98% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -33 thousand shares and in total, 234 thousand shares were bought and sold for approximately $2.01 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 453.74% during the next 3 months and, with a 90% probability hold a price between $24.28 and $77.36 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

OTLK Signals & Forecast

The Outlook Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $9.03. On a fall, the stock will find some support from the long-term average at approximately $5.63. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -27.81%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Outlook Therapeutics Inc. stock

Outlook Therapeutics Inc. finds support from accumulated volume at $8.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.350 between high and low, or 4.15%. For the last week, the stock has had daily average volatility of 7.03%.

Our recommended stop-loss: $8.10 (-5.98%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 11 days ago.)

Trading Expectations (OTLK) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Outlook Therapeutics Inc. to open at $8.62, and during the day (based on 14 day Average True Range), to move between $7.53 and $9.71, which gives a possible trading interval of +/-$1.09 (+/-12.64%) up or down from last closing price. If Outlook Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 25.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.63 (0.12%) than the support at $8.51 (1.28%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Outlook Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.641 Buy Candidate Unchanged

Predicted Opening Price for Outlook Therapeutics Inc. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$8.62 ( 0.0387%) $8.62

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OTLK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.97 4.02 %
R2 8.83 2.47 %
R1 8.75 1.51 %
Current price: 8.62
Support S1 8.48 -1.59 %
S2 8.40 -2.55 %
S3 8.27 -4.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.26 19.03 %
R2 9.37 8.70 %
R1 8.63 0.116 %
Current price 8.62
Support S1 8.51 -1.28%
S2 8.24 -4.41%
S3 7.79 -9.69%

FAQ

What is the symbol for Outlook Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Outlook Therapeutics Inc. is OTLK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Outlook Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.

How to buy Outlook Therapeutics Inc. Stock?
Outlook Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Outlook Therapeutics Inc. Stock.

What's the current price of Outlook Therapeutics Inc. Stock?
As of the end of day on the 2024-04-15, the price of an Outlook Therapeutics Inc. (OTLK) share was $8.62.

What is the 52-week high and low for Outlook Therapeutics Inc. Stock?
The 52-week high for Outlook Therapeutics Inc. Stock is $12.85 and the 52-week low is $0.200.

What is the market capitalization of Outlook Therapeutics Inc. Stock?
As of the 2024-04-15, the market capitalization of Outlook Therapeutics Inc. is 186.057M.

When is the next earnings date for Outlook Therapeutics Inc.?
The upcoming earnings date for Outlook Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT